沙坦类药物 市场调研报告
班级：生化制药30904 姓名：史 蓓 学号：9号
日期：2011.9.1——2011.10.26
目录
摘要·····································································1
第一节国内抗高血压药物市场分析·····························2 全球高血压患病情况 ···············································2 我国现有高血压病人数量及高血压疾病的特点·······················2 我国抗高血压用药的个性化特点·····································2 沙坦类降血压药的效益··············································3
第二节沙坦类降血压药的发展···································3
第三节沙坦类降血压药分类······································5
第四节沙坦类抗高血药市场特点································5 全球已上市应用的沙坦类降压药···········································5 国内沙坦类药物生产企业··················································6 国内仿制沙坦类降压药现况················································8 原研品牌保持较高的市场份额的原因·······································8
第五节沙坦类抗高血药市场营销环境研究·····················11 临床应用及适应症·························································12 沙坦类降压药的优势·······················································12 沙坦类降压药的劣势·······················································13 沙坦类药物研发···························································14 沙坦类药物生产技术·······················································15 沙坦类药物所占市场份额··················································15 国内沙坦类原料竞争相对稳定 ············································16
第六节消费者购买行为···········································17
第七节沙坦类药物市场细分····································18
第八节ACE抑制剂和沙坦类药物的市场比较···············19
第九节沙坦类药物市场前景良好································20 沙坦类药物价格优势·······················································21 沙坦类药物产品品质优势··················································22 国家政策··································································22
第十节沙坦类药物市场综合分析································23 参考文献································································24
